Secretome analysis identifies novel signal peptide peptidase-like 3 (Sppl3) substrates and reveals a role of Sppl3 in multiple golgi glycosylation pathways

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Peer Hendrik Kuhn - , German Center for Neurodegenerative Diseases (DZNE) (Author)
  • Matthias Voss - , Ludwig Maximilian University of Munich, Karolinska Institutet (Author)
  • Martina Haug-Kröper - , Ludwig Maximilian University of Munich (Author)
  • Bernd Schröder - , Institute of Physiological Chemistry, Kiel University (Author)
  • Ute Scheperse - , Karlsruhe Institute of Technology, Munich Cluster for Systems Neurology (SyNergy) (Author)
  • Stefan Bräse - , Karlsruhe Institute of Technology, Munich Cluster for Systems Neurology (SyNergy) (Author)
  • Christian Haass - , German Center for Neurodegenerative Diseases (DZNE), Ludwig Maximilian University of Munich (Author)
  • Stefan F. Lichtenthaler - , German Center for Neurodegenerative Diseases (DZNE), Technical University of Munich (Author)
  • Regina Fluhrer - , German Center for Neurodegenerative Diseases (DZNE), Ludwig Maximilian University of Munich, Munich Cluster for Systems Neurology (SyNergy), Technical University of Munich (Author)

Abstract

Signal peptide peptidase-like 3 (Sppl3) is a Golgi-resident intramembrane-cleaving protease that is highly conserved among multicellular eukaryotes pointing to pivotal physiological functions in the Golgi network which are only beginning to emerge. Recently, Sppl3 was shown to control protein N-glycosylation, when the key branching enzyme N-acetylglucosaminyltransferase V (GnT-V) and other medial/trans Golgi glycosyltransferases were identified as first physiological Sppl3 substrates. Sppl3-mediated endoproteolysis releases the catalytic ectodomains of these enzymes from their type II membrane anchors. Protein glycosylation is a multistep process involving numerous type II membrane-bound enzymes, but it remains unclear whether only few of them are Sppl3 substrates or whether Sppl3 cleaves many of them and thereby controls protein glycosylation at multiple levels. Therefore, to systematically identify Sppl3 substrates we used Sppl3- deficient and Sppl3-overexpression cell culture models and analyzed them for changes in secreted membrane protein ectodomains using the proteomics "secretome protein enrichment with click sugars (SPECS)" method. SPECS analysis identified numerous additional new Sppl3 candidate glycoprotein substrates, several of which were biochemically validated as Sppl3 substrates. All novel Sppl3 substrates adopt a type II topology. The majority localizes to the Golgi network and is implicated in Golgi functions. Importantly, most of the novel Sppl3 substrates catalyze the modification of N-linked glycans. Others contribute to O-glycan and in particular glycosaminoglycan biosynthesis, suggesting that Sppl3 function is not restricted to N-glycosylation, but also functions in other forms of protein glycosylation. Hence, Sppl3 emerges as a crucial player of Golgi function and the newly identified Sppl3 substrates will be instrumental to investigate the molecular mechanisms underlying the physiological function of Sppl3 in the Golgi network and in vivo. Data are available via ProteomeXchange with identifier PXD001672.

Details

Original languageEnglish
Pages (from-to)1584-1598
Number of pages15
JournalMolecular and Cellular Proteomics
Volume14
Issue number6
Publication statusPublished - 1 Jun 2015
Peer-reviewedYes

External IDs

PubMed 25827571

Keywords